Bumper Offer - Urjas oil Just @ Rs. 1
Etoshine NP is an allopathic medicine The correct dosage of Etoshine NP depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Etoshine NP is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Etoshine NP is used -
Moderate
Mild
Common
Is the use of Etoshine NP safe for pregnant women?
Pregnant women may experience moderate side effects from Etoshine NP. It is best to stop taking Etoshine NP immediately and inform your doctor if you notice any discomfort.
Is the use of Etoshine NP safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Etoshine NP. It should only be taken after medical advice.
What is the effect of Etoshine NP on the Kidneys?
Etoshine NP may have mild side effects on the kidneys.
What is the effect of Etoshine NP on the Liver?
Etoshine NP does not damage the liver.
What is the effect of Etoshine NP on the Heart?
There are no any side effects of Etoshine NP for the heart.
Etoshine NP should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Etoshine NP unless your doctor advises you to do so -
Is this Etoshine NP habit forming or addictive?
Etoshine NP is not addictive in nature.
Interaction between Food and Etoshine NP
Taking Etoshine NP with food does not cause any problems.
Interaction between Alcohol and Etoshine NP
Consuming Etoshine NP with alcohol can have many serious effects on your body.
It is recommended to avoid taking Etoshine NP with ibuprofen because both belong to the same category which may increase the risk of side effects associated with the GIT (Gastrointestinal tract). Hence you must consult a doctor before taking these two medicines together.
Yes, Etoshine NP can increase blood pressure (BP) in some people, if taken a higher dose. It may increase the chance of stroke and heart attack. You are recommended to get your blood pressure regularly checked. A low sodium diet also helps in maintaining blood pressure. Inspite of all efforts if your blood pressure fluctuates then do consult a physician.
Etoshine NP is a prescription drug so do not take it without consulting a doctor. It can be harmful to consume this medicine if you don't require it.
No, Etoshine NP is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take this medicine without a doctor's recommendation because Etoshine NP can cause severe intestinal bleeding, severe allergic reaction, and severe stomach problem. Hence patient should seek doctors advice before taking this medication by himself.
Yes, Etoshine NP can cause weight fluctuation (weight gain and loss). It is uncommon side effects of this drug. Few people may experience this effect after consuming this drug. People should monitor their weight, eat healthily and include at least 30 mins of exercising in a day. In spite of all efforts if you experience weight gain then discuss with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420